Coronavirus vaccine in US by year-end if regulators approve candidate, says Pfizer CEO

According to Pfizer CEO Albert Bourla, the company’s study will show if there is a “good chance if the product works” by October-end, distribution would depend on license issuances from regulators such as the FDA

from Moneycontrol Business News https://ift.tt/35xYZsp